SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 13 | Q2 13 | Q3 13 | Q4 13 | Q1 14 | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 29.8% | 22.1% | 33.9% | 24.2% | 24.2% | 25.0% | 29.1% | 25.6% | 25.1% | 17.8% | 33.1% | 42.2% | 42.2% | 271.4% | 19.9% | 26.5% | 11.6% | 11.6% | 26.5% | 11.6% | 5.9% | 14.0% | 8.6% | 10.3% | 10.3% | 9.5% | 16.1% | 12.9% | 12.9% | 14.4% | 12.2% | 13.3% | 13.3% | 5.8% | 5.2% | 21.0% | 153.3% | 77.5% | 134.2% | – | |
| 70.2% | 77.9% | 66.1% | 75.8% | 75.8% | 75.0% | 70.9% | 74.4% | 74.9% | 82.2% | 66.9% | 57.8% | 57.8% | -171.4% | 80.1% | 73.5% | 88.4% | 88.4% | 73.5% | 88.4% | 94.1% | 86.0% | 91.4% | 89.7% | 89.7% | 90.5% | 83.9% | 87.1% | 87.1% | 85.6% | 87.8% | 86.7% | 86.7% | 94.2% | 94.8% | 79.0% | -53.3% | 22.5% | -34.2% | 100.0% | |
| 18.4% | 11.7% | 9.2% | 12.6% | 12.6% | 27.0% | 14.8% | 17.3% | 23.9% | 12.0% | 13.2% | 18.9% | 18.9% | 202.0% | 14.7% | 11.4% | 13.1% | 13.1% | 11.4% | 10.9% | 8.9% | 7.8% | 8.7% | 12.3% | 12.3% | 9.9% | 8.8% | 37.0% | 37.0% | 27.6% | 22.5% | 0.8% | 0.8% | 0.5% | 1.2% | 15.2% | 91.9% | 23.7% | 107.6% | 62.8% | |
| 66.2% | 50.8% | 51.1% | 46.5% | 71.3% | 99.1% | 65.7% | 45.6% | 73.0% | 49.7% | 61.9% | 101.9% | 58.9% | 623.1% | 44.4% | 49.7% | 54.9% | 68.8% | 5,447.0% | 58.4% | 53.8% | 59.8% | 52.5% | 184.4% | 63.8% | 47.7% | 53.5% | 213.5% | 107.6% | 58.7% | 40.9% | 25.4% | – | – | – | – | – | – | – | – | |
| 92.2% | 65.5% | 52.5% | 71.3% | 71.3% | 99.1% | 65.7% | 64.7% | 96.8% | 59.3% | 74.7% | 73.4% | 73.4% | 824.3% | 58.0% | 41.5% | 80.3% | 68.8% | 41.5% | 58.4% | 62.5% | 67.6% | 61.0% | 76.0% | 76.0% | 57.6% | 62.2% | 144.5% | 144.5% | 85.9% | 63.7% | 26.5% | 26.5% | 2.0% | 6.4% | 28.1% | 331.2% | 63.6% | 272.5% | 120.3% | |
| -21.9% | 12.4% | 13.6% | 11.4% | 4.5% | -24.4% | 5.2% | 9.5% | -21.8% | 23.0% | -7.8% | -11.1% | -16.1% | -1,001.4% | 21.1% | 31.8% | 19.7% | 19.7% | 31.8% | 29.9% | 31.5% | 18.4% | 30.3% | 13.5% | 13.5% | 32.9% | 21.4% | -57.4% | -57.4% | -0.4% | 24.0% | 60.1% | 60.1% | 92.3% | 88.4% | 50.9% | -384.5% | -12.0% | -306.7% | -40.0% | |
| 6.6% | 4.4% | 3.3% | 5.5% | 5.5% | 6.9% | 5.3% | 4.5% | 6.4% | 2.3% | 2.9% | 3.5% | 3.5% | 29.1% | 1.2% | 1.9% | 1.2% | 1.2% | 1.9% | 0.7% | 0.8% | 0.4% | 0.5% | 0.5% | 0.5% | 0.3% | 0.2% | 1.4% | 1.4% | 0.7% | 0.5% | 0.1% | 0.1% | 0.0% | 0.0% | 0.1% | 0.2% | 0.1% | 0.2% | 0.6% | |
| -23.5% | 11.0% | 13.3% | 5.8% | 5.8% | -24.4% | 3.1% | 13.6% | -22.8% | 22.4% | -9.1% | -15.0% | -15.0% | -1,016.9% | 20.3% | 30.0% | 19.3% | 19.3% | 30.0% | 29.9% | 31.8% | 18.7% | 31.0% | 14.1% | 14.1% | 33.7% | 22.6% | -55.0% | -55.0% | -0.2% | 23.2% | 60.6% | 60.6% | 60.8% | 58.3% | 51.2% | -203.1% | -11.9% | -11.9% | -29.0% | |
| 0.0% | 0.0% | 0.3% | 2.6% | 2.6% | 0.6% | 2.4% | 3.0% | 6.0% | 2.4% | 1.6% | -0.5% | -0.5% | -104.6% | 5.4% | 8.3% | -4.4% | -4.4% | 8.3% | 10.5% | 6.0% | 4.9% | 6.4% | 4.3% | 4.3% | 7.0% | 4.4% | -6.9% | -6.9% | 2.2% | 4.9% | 7.8% | 7.8% | 14.3% | 18.3% | 11.2% | -70.9% | -6.8% | -23.9% | 45.1% | |
| -20.0% | 7.6% | 10.5% | 3.3% | 0.0% | -18.6% | 0.5% | 6.4% | -24.4% | 12.3% | -9.5% | -14.5% | 11.9% | -694.2% | 11.2% | 14.2% | 16.2% | 16.2% | 14.2% | 13.9% | 17.7% | 7.6% | 16.4% | 9.8% | 4.9% | 19.0% | 12.1% | -48.1% | -38.1% | -7.2% | 9.7% | 52.7% | 33.2% | 46.5% | 40.0% | 40.0% | -132.2% | -5.0% | 12.0% | -38.0% | |
| 0.0% | 25.6% | 24.2% | 31.3% | 31.3% | -1.2% | 13.0% | 28.5% | 0.7% | 34.1% | 3.1% | 2.6% | 1.7% | -883.7% | 25.8% | 27.7% | – | 22.8% | 35.0% | 32.3% | 35.3% | 20.9% | 34.0% | 17.7% | 17.6% | 35.8% | 24.7% | -48.1% | -48.2% | 3.6% | 24.0% | 61.1% | 61.0% | 92.4% | 89.0% | 57.3% | -293.0% | -12.3% | 14.8% | -8.7% |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.